Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors

Journal of Urology

Volumn 174, Issue 2, 2005, Pages 636-641

  Fleshner, Neil ^a,c   Harvey, Melissa ^a   Adomat, Hans ^b   Wood, Catherine ^b   Eberding, Andy ^b   Hersey, Karen ^a   Guns, Emma ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Complementary therapies; Contraindications; Government regulation; Impotence; Phosphodiesterase inhibitors

Indexed keywords

BIOVIGORA; HERBACEOUS AGENT; HERBAL EROTICA; HERBAL VIAPHRODISIAC; NATURAL PRODUCT; NITRATE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; STAMINA RX; SUPER X; TADALAFIL; VARDENAFIL; VIP VIGA; VUKA VUKA;

ARTICLE; DEATH; DRUG CONTAMINATION; DRUG CONTRAINDICATION; DRUG CROSS REACTIVITY; DRUG LEGISLATION; DRUG MARKETING; ERECTILE DYSFUNCTION; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTENSION; INTERNET; MASS SPECTROMETRY; PRIORITY JOURNAL; SHOCK; TABLET;

EID: 22144457058     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000165187.31941.cd     Document Type: Article

References (14)

1. Miller, F. G., Emanuel, E. J., Rosenstein, D. L. and Straus, S. E.: Ethical issues concerning research in complementary and alternative medicine. JAMA, 291: 599, 2004
2. Gordon, A. E. and Shaughnessy, A. F.: Saw palmetto for prostate disorders. Am Fam Physician, 67: 1281, 2003
3. Nam, R. K., Fleshner, N., Rakovitch, E., Klotz, L., Trachtenberg, J., Choo, R. et al: Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol, 161: 1521, 1999
4. Keith, A.: The economics of Viagra. Health Aff, 19: 147, 2000
5. Shah, J.: Erectile dysfunction through the ages. BJU Int, 90: 433, 2002
6. Smith, E. R.: Natural health products and government regulation. Can J Cardiol, 19: 947, 2003
7. Sheldon, T.: Netherlands to crack down on complementary medicine. BMJ, 328: 485, 2004
8. Oh, W. K. and Small, E. J.: Complementary and alternative therapies in prostate cancer. Semin Oncol, 29: 575, 2002
9. Guns, E. S., Goldenberg, S. L. and Brown, P. N.: Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol. Can J Urol, 9: 1684, 2002
10. Sovak, M., Seligson, A. L., Konas, M., Hajduch, M., Dolezal, M., Machala, M. et al: Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst, 94: 1275, 2002
11. Gordon, N. P. and Lin, T. Y.: Use of complementary and alternative medicine by the adult membership of a large northern California health maintenance organization, 1999. J Ambul Care Manage, 27: 12, 2004
12. Lyngdorf, P. and Hemmingsen, L.: Epidemiology of erectile dysfunction and its risk factors: a practice-based study in Denmark. Int J Impot Res, 16: 105, 2004
13. Araujo, A. B., Mohr, B. A. and McKinlay, J. B.: Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc, 52: 1502, 2004
14. Tran, D. and Howes, L. G.: Cardiovascular safety of sildenafil. Drug Saf, 26: 453, 2003